Inhibition on Hepatitis B virus in vitro of recombinant MAP30 from bitter melon

Risk factors for hepatocellular carcinoma: Synergism of alcohol with viral hepatitis and diabetes mellitus

Manal M. Hassan, Lu-Yu Hwang, Chiq J. Hatten et al. · Hepatology · 2002 · 762 citations · Full text

Medicine, Oncology, Pathology +17

The National Cancer Institute: cancer drug discovery and development program.

Michael R. Grever, Saul A. Schepartz, B A Chabner · PubMed · 1992 · 721 citations

Medicine, Cancer Biology, Oncology +11

Hepatitis B Virus Replication Is Regulated by the Acetylation Status of Hepatitis B Virus cccDNA-Bound H3 and H4 Histones

Teresa Pollicino, Laura Belloni, G. Raffa et al. · Gastroenterology · 2006 · 461 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +11

HBV genotype B is associated with better response to interferon therapy in HBeAg(+) chronic hepatitis than genotype C

C Wai · Hepatology · 2002 · 309 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

MAP 30: a new inhibitor of HIV‐1 infection and replication

Sylvia Lee‐Huang, Philip L. Huang, Peter L. Nara et al. · FEBS Letters · 1990 · 205 citations · Full text

Life Sciences, Molecular Biology, Pharmacology +16